ArticlePloS one2026
Pneumococcal nasopharyngeal carriage, serotype distribution, and vaccination status in hospitalized children in Latvia: A cross-sectional study during the post-PCV13, pre-PCV15/PCV20 transition period.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Streptococcus pneumoniae remains a leading cause of invasive disease in children, and nasopharyngeal carriage surveillance is essential for monitoring vaccine-driven changes in serotype distribution. However, carriage data from the Baltic states are scarce. We conducted a cross-sectional study to assess pneumococcal carriage prevalence, serotype distribution, and associated factors in 321 hospitalized children aged 0-18 years at the Children's Clinical University Hospital of Latvia between January 2021 and September 2022, a period representing the post-PCV13, pre-PCV15/PCV20 era. Pneumococcal carriage was detected by PCR targeting the lytA and sp2020 genes; serotyping was performed on PCR-positive samples. Overall carriage prevalence was 21.8% (70/321; 95% CI: 17.6-26.6%). Of the PCR-positive samples, 78.6% (55/70) were non-typeable and only 21.4% (15/70) yielded identifiable serotypes. Among these 15 typeable isolates, the most frequently detected serotypes were 20, 13, and 48, appearing in complex combinations, followed by 15A/15F, 23B1/23B, and 09N/09L-none of which are covered by PCV13; given the small number of typeable isolates, serotype findings are exploratory. PCV vaccination coverage was 63.2% (203/321), with PCV10 (Synflorix) predominating. No significant association was found between vaccination status and carriage prevalence (vaccinated: 25.6% vs. unvaccinated: 16.7%; p = 0.138). Children aged 1-5 years had the highest carriage prevalence at 30.9%. These data constitute the first comprehensive pneumococcal carriage assessment from the Baltic region during this transitional period and may serve as a reference for evaluating the impact of PCV15 and PCV20 following their introduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.